Eli Lilly and Company (LLY)
Today's Latest Price: $212.35 USD
Updated Jan 25 6:40pm
Add LLY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ELI LILLY & Co (LLY) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ELI LILLY & Co.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 18 | $227 | $150 | $197.08 | $206.14 | -4.4% |
LLY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 4 | 8 | 9 | 0 | 0 | NA |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- LLY has a higher average analyst price target than 93.56% of all US stocks.
- ELI LILLY & Co's number of analysts covering the stock is greater than 95.45% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of LLY is greater than 11.67% of Pharmaceutical Products stocks.
- LLY has a lower variance in analysts' estimates than 60.91% of Pharmaceutical Products stocks.
- LLY has a lower percent of analysts bearish on the stock than almost 100% of all US stocks.
- LLY has a greater percentage of analysts bullish on the stock than practically none of all US stocks.
- The change in bullishness amongst analysts of LLY is less than almost 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ELI LILLY & Co are SGEN, ZTS and JNJ.
What is the outlook for LLY? Use POWR Ratings for clearer insight into price direction.